RPS26P34

Across TCGA pan-cancer cohorts, RPS26P34 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPS26P34 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPS26P34 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS26P34 expression acts as an unfavorable survival marker, although some lineages such as GBM and COAD show a favorable association.

BLCA, KICH, and ESCA are the cancer types where RPS26P34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.197	0.377	<.001	72	view →
KICH	OS	Quartile	II,III,IV	0.305	0.874	.001	57	view →
ESCA	DFS	Tertile	All	0.462	0.666	.005	26	view →
STAD	OS	Tertile	All	0.457	0.682	.022	16	view →
THCA	DFS	Tertile	III,IV	0.637	0.897	.013	15	view →
THYM	OS	Quartile	II,III,IV	0.843	0.969	.012	10	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	9	view →
UVM	OS	Tertile	III,IV	0.220	0.872	.025	9	view →
LIHC	OS	Tertile	All	0.673	0.807	.017	9	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.038	9	view →
GBM	OS	Quartile	All	0.621	0.344	.024	6	view →
LUSC	DFS	Quartile	III,IV	0.274	0.831	.006	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPS26P34–BLCA (DFS)

Open the BLCA breakdown →